Bryan, TX (PRWEB) March 11, 2014
The Caliber Biotherapeutics’ manufacturing facility in Bryan, Texas received the 2014 Pharmaceutical Processing Facility Excellence Award. Caliber Biotherapeutics represents a facility and production outlook, which will have a substantial impact in bioproductions of the future. To address the need for rapid responses of large vaccine requirements and to gain a more robust, fast and cost-effective expression system for monoclonal antibodies, Caliber Biotherapeutics employs a plant expression system that relies in part on the ability to grow 2.2 million plants in a multi-level hydroponic configuration. In addition, to be able to fully utilize the facility as a multi-product site, the entire downstream process is integrated in autonomous cleanroom PODs, developed, designed and commissioned by G-CON Manufacturing, LLC. This commitment to new and innovative drug development and production strategies has led to Pharmaceutical Processing’s awarding Caliber a Facility Excellence Award for 2014.
“We are very excited that a ‘podified’ manufacturing site received this prestigious and well- recognized award,” said Maik Jornitz, Chief Operating Officer of G-CON Manufacturing LLC. “We congratulate Caliber Biotherapeutics on the award and their vision of agile, flexible and economic bioprocessing. Caliber’s use of our cleanroom PODs in their R&D and downstream processes supports that vision and demonstrates that production flexibility requires new designs of cleanrooms. The traditional approach is no longer sufficient in the current market Caliber has not only recognized this trend but has acted on it as well.”
G-CON Manufacturing has been an intricate part of the Caliber Biotherapeutic site and process development. Caliber’s input and requirement needs have substantially advanced the G-CON Manufacturing cleanroom POD product portfolio. Caliber’s R&D needs were addressed recently with small scale PODs and that line will be further extended to analytical, microbial and assay development laboratory offerings.
G-CON provides the resources and experience to transform the industry by providing unmatched manufacturing flexibility. G-CON’s founders have significant experience in designing, building, operating, and maintaining a variety of traditional biomanufacturing facilities. They are familiar with the excessive cost to build, lack of flexibility, and high expense to maintain these traditional facilities and have leveraged this experience to create the G-CON POD™ solution. Moreover, the G-CON team understands that future facility designs must be multipurpose and repurposable, instead of fixed and specialized with ineffective capacity utilization.